The Relaxin for the Treatment of Acute Heart Failure ( RELAX-AHF ) trial enrolled @ patients admitted to the hospital for acute heart failure ( AHF ) to evaluate the therapeutic efficacy of serelaxin , a recombinant form of human relaxin-@ .